![Fotis Sakellaridis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fotis Sakellaridis
Algemeen Directeur bij Qualia Pharma
Vermogen: 42 M $ op 30-06-2024
Profiel
Fotis Sakellaridis is currently the Chief Executive Officer at Qualia Pharma.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
IDNA GENOMICS PUBLIC LTD
52.00% | 21-04-2023 | 1 435 373 ( 52.00% ) | 42 M $ | 30-06-2024 |
Actieve functies van Fotis Sakellaridis
Bedrijven | Functie | Begin |
---|---|---|
Qualia Pharma
![]() Qualia Pharma Pharmaceuticals: MajorHealth Technology Qualia Pharma manufactures pharmaceuticals products. It specializes in nutraceuticals and medcal devices. The company was founded in 2009 and is headquartered in Attiki, Greece. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Qualia Pharma
![]() Qualia Pharma Pharmaceuticals: MajorHealth Technology Qualia Pharma manufactures pharmaceuticals products. It specializes in nutraceuticals and medcal devices. The company was founded in 2009 and is headquartered in Attiki, Greece. | Health Technology |